
G-Heparin25000 IU/5
Gonoshasthaya Pharmaceuticals Limited
Heparin Sodium is an injectable anticoagulant with the following established uses: FDA-Approved / Established Indications Prophylaxis and treatment of venous thrombosis and pulmonary embolism…
Heparin Sodium is an injectable anticoagulant with the following established uses:
Use of Heparin Sodium should always be guided by a physician based on individual risk factors, coagulation status, and monitoring capability.
Dosage of Heparin Sodium must be individualized and is usually monitored using activated partial thromboplastin time (aPTT) for therapeutic (full-dose) regimens. Low-dose prophylactic regimens generally do not require routine aPTT monitoring.
| Indication | Typical Adult Dosage |
|---|---|
| Deep vein thrombosis / pulmonary embolism (therapeutic) | Initial IV bolus of 5,000 units, followed by continuous IV infusion of 20,000-40,000 units/24 hours, adjusted to maintain target aPTT; alternatively, intermittent IV or deep subcutaneous dosing per protocol |
| Postoperative DVT prophylaxis (low-dose) | 5,000 units subcutaneously 2 hours before surgery, then every 8-12 hours during the period of risk |
| Cardiovascular / cardiopulmonary bypass surgery | 150-400 units/kg IV depending on procedure duration, per institutional protocol |
| Line/catheter patency (flush) | Low-dose heparin flush solution as per catheter manufacturer/hospital protocol |
Loading dose of approximately 75-100 units/kg IV bolus, followed by a maintenance infusion of about 18-30 units/kg/hour, adjusted to maintain target aPTT; dosing must be individualized under specialist supervision, and only preservative-free Heparin Sodium should be used in neonates and infants.
No formal dose-adjustment protocol is established; however, clearance may be reduced in significant hepatic or renal impairment, so more frequent coagulation monitoring and cautious dose titration are recommended.
See Precautions and Warnings for essential monitoring requirements and the boxed warning on medication errors related to varying vial concentrations.
Common and serious adverse effects associated with Heparin Sodium include:
Report any unusual bleeding, bruising, or signs of allergic reaction to a physician immediately.
Heparin Sodium is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.